---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-112887"
form_type: "8-K"
ticker: "ADGM"
cik: "0002006986"
company_name: "Adagio Medical Holdings, Inc."
filed_at: "2026-10-01T21:08:10+00:00"
generated_at: "2026-10-12T14:27:50.098522+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Adagio Medical Holder Converts $776,111 of 13% Notes Into 4,978,869 Shares

## Summary
- A holder converted $776,111 aggregate principal of Adagio Medical's 13% Senior Secured Convertible Notes between September 25 and October 1, 2026.
- The conversion issued 4,978,869 shares of Common Stock at Alternate Conversion Prices ranging from $0.1265 to $0.1618 per share.
- Adagio had lowered the Notes' Conversion Price from September 23 through October 31, 2026 to the Alternate Conversion Price in effect on each conversion date.
- Shares were issued under the Section 3(a)(9) exemption, with no commission or other remuneration paid for soliciting the exchange.
- The 8-K was signed by Deborah Kaster, Chief Financial Officer and Chief Business Officer, and dated October 1, 2026.

## SEC filing metadata
- accession: 0001104659-26-112887
- form_type: 8-K
- ticker: ADGM
- cik: 0002006986
- company_name: Adagio Medical Holdings, Inc.
- filed_at: 2026-10-01T21:08:10+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2006986/000110465926112887/0001104659-26-112887-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2006986/000110465926112887/tm2626864d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-112887
- JSON: https://secwatch.observer/filing/0001104659-26-112887.json
- Plain text: https://secwatch.observer/filing/0001104659-26-112887.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.